CEL-SCI Corporation
General ticker "CVM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $30.7M (TTM average)
CEL-SCI Corporation follows the US Stock Market performance with the rate: 0.5%.
Estimated limits based on current volatility of 4.8%: low 4.33$, high 4.77$
Factors to consider:
- Total employees count: 17381 as of 1995
- Top business risk factors: Substantial doubt about continuing as a going concern, Regulatory and compliance, High development costs, Product liability, Equity dilution
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [3.50$, 14.21$]
- 2026-09-30 to 2027-09-30 estimated range: [2.29$, 9.68$]
Short-term CVM quotes
Long-term CVM plot with estimates
Financial data
| YTD | 2025-09-30 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $24.81MM |
| Operating Income | $-24.81MM |
| Non-Operating Income | $-0.60MM |
| Interest Expense | $0.65MM |
| R&D Expense | $15.89MM |
| Income(Loss) | $-25.41MM |
| Profit(Loss)* | $25,360.23MM |
| Stockholders Equity | $15.96MM |
| Inventory | $0.30MM |
| Assets | $28.16MM |
| Operating Cash Flow | $-17,119.74MM |
| Capital expenditure | $38.11MM |
| Investing Cash Flow | $-38.11MM |
| Financing Cash Flow | $23,373.13MM |
| Earnings Per Share** | $6,252.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.